 recombin human granulocyte-macrophag colony-stimul factor chemotherapi patient acut myeloid leukemia age relaps critic neutropenia chemotherapi CT acut myeloid leukemia aml recombin human granulocyte-macrophag colony-stimul factor gm-csf patient age year aml patient earli second relaps CT ara-c daunorubicin aml sequenti high-dos ara-c mitoxantron s-ham relaps patient bone marrow free continu intraven infus gm-csf day thirty-six patient studi gm-csf comparison histor control group patient complet remiss rate versu control earli death rate treatment gm-csf major advers event patient mark leukem regrowth revers patient gm-csf independ patient remiss durat gm-csf gm-csf blood neutrophil day s-ham group rapid clearanc infect patient gm-csf therapeut benefit patient basi control trial